How To | Cost Effectiveness of Health

Financial Sustainability Report: July 2021

Sponsored by Kaufman Hall
How To | Cost Effectiveness of Health

Financial Sustainability Report: July 2021

The July 2021 issue of the Financial Sustainability Report, sponsored by Kaufman Hall, includes an account of how one health system assessed the benefits and risk associated with moving its  340B covered-entity pharmacy enterprise to a Limited Liability Company. The issue also includes a commentary on CMS’s new Acute Hospital Care at Home program and a discussion of a new metric, equivalent net patient revenue (ENPR), which organizations can use to assess the relative value of proposed investments in alternative revenue sources.

Pharmacy Services and 340B

Weighing the feasibility of an LLC-owned retail pharmacy enterprise
By Nathan Hagen, Ian Macdonald, Linda  Tyler and Nancy Nickman
University of Utah Hospitals and Clinics (UUHC) in Salt Lake City performed research to assess the feasibility of moving its 340B covered-entity pharmacy enterprise to a Limited Liability Corporation (LLC), with a focus on risks that should be factored into the decision. Other organizations that are considering such a move could benefit from adopting UUHC’s assessment approach.

Physician enterprise

Maintaining the equilibrium of the physician enterprise amid rapid change is a matter of balance
Sponsored by Kaufman Hall
By Matthew Bates and David Masters
To ensure the proper functioning of the physician enterprise, hospitals and health systems must establish a balance among three dimensions: The clinicians’ productivity, the capacity to provide patients with access to care when they need it, and he volume of existing and potential patients in the market.

CMS hospital at home program

Commentary
Hospital care at home signifies an important innovation in acute care delivery
By Shawn W. Stack
Although the CMS Acute Hospital Care at Home program is still early in its development, early adopters show evidence of the program’s exciting promise, including positive impacts on health outcomes, an improved patient and provider experience, reduced cost of care and overall healthcare savings.

Strategic investment

ENPR: A metric for comparing alternative and top-line revenue strategies to enhance strategic growth
By Jami Youmans, MHA, Kyle Hathaway and Ryan Smith, CFA 
Health system CFOs today should be actively guiding their organizations toward strategic investments in alternative revenue sources that can strengthen the bottom line. An effective and relatable metric for evaluating such investments is equivalent net patient revenue (ENPR)

 

Sign up for a free guest account and get access to five free articles every month.

Advertisements

Related Articles | Cost Effectiveness of Health

News | Payment Models

Accountable care models will be almost universal for Medicare and Medicaid beneficiaries by 2030, CMS leaders say

A forthcoming revamp of federal value-based payment models will include features designed to encourage provider participation, CMS and CMMI leaders said.

Column | Leadership

Healthcare’s top area of vulnerability: What finance leaders need to know

HFMA President and CEO Joseph J. Fifer discusses recent survey findings that cost effectiveness is not only a weak spot for hospitals and health systems but also healthcare’s No. 1 area of vulnerability to disruption.

News | Cost Effectiveness of Health

The stakes are only growing in efforts to improve the cost effectiveness of health, CMMI’s Elizabeth Fowler says

The head of the Center for Medicare & Medicaid Innovation spoke with an HFMA audience about the importance of efforts at the federal level and beyond to improve the cost effectiveness of health.

News | Cost Effectiveness of Health

HFMA’s Fifer, international panelists discuss how to improve investment in health

HFMA President and CEO Joe Fifer participated in an international summit that included a session on bolstering health through appropriate investment strategies.